Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab | Zendy

André J. Witkin | Zendy; Paul Hahn | Zendy; Timothy G. Murray | Zendy; J. Fernando Arévalo | Zendy; Kevin J. Blinder | Zendy; Netan Choudhry | Zendy; Geoff G. Emerson | Zendy; Roger A. Goldberg | Zendy; Stephen J. Kim | Zendy; Joel Pearlman | Zendy; Eric W. Schneider | Zendy; Homayoun Tabandeh | Zendy; Robert W. Wong | Zendy

AI Assistant Blog Pricing

Open Access

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab

Author(s) -

André J. Witkin,

Paul Hahn,

Timothy G. Murray,

J. Fernando Arévalo,

Kevin J. Blinder,

Netan Choudhry,

Geoff G. Emerson,

Roger A. Goldberg,

Stephen J. Kim,

Joel Pearlman,

Eric W. Schneider,

Homayoun Tabandeh,

Robert W. Wong

Publication year - 2020

Publication title -

journal of vitreoretinal diseases

Language(s) - English

Resource type - Journals

eISSN - 2474-1272

pISSN - 2474-1264

DOI - 10.1177/2474126420930863

Subject(s) - retinal vasculitis , medicine , retinal , vasculitis , ophthalmology , asymptomatic , macular degeneration , visual acuity , adverse effect , retina , surgery , pathology , disease , physics , optics

To analyze a case series of retinal vasculitis reported to the American Society of Retina Specialists (ASRS) following Food and Drug Administration approval of brolucizumab for treatment of neovascular age-related macular degeneration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog